Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Salivart is a brand-name synthetic saliva substitute designed to provide temporary relief from xerostomia (dry mouth) and associated oral discomfort. It is formulated to mimic the chemical and physical properties of natural human saliva, providing essential lubrication and moisture to the oral mucosa. The product is commonly used by patients experiencing dry mouth due to conditions such as Sjögren's syndrome, medication side effects, chemotherapy, or head and neck radiation therapy. Salivart typically contains a combination of electrolytes (including sodium, potassium, calcium, and magnesium salts) and a thickening agent, such as carboxymethylcellulose, to achieve a viscosity similar to natural saliva. It is applied topically to the mouth and throat and is not intended for systemic absorption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Salivart.